Mucinex Line Extensions Underscore Adams’ Commitment To Building OTCs

A major task facing Adams Respiratory Therapeutics' new VP-OTC Marketing & Business Development Robert Casale will be to plan a Fall 2004 launch of extensions to the firm's Mucinex expectorant brand